Candriam S.C.A. trimmed its position in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 10.1% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 590,173 shares of the company’s stock after selling 66,250 shares during the quarter. Candriam S.C.A.’s holdings in Procter & Gamble were worth $86,054,000 at the end of the most recent reporting period.
Several other large investors also recently bought and sold shares of the company. American State Bank Iowa raised its stake in shares of Procter & Gamble by 4.9% during the 3rd quarter. American State Bank Iowa now owns 13,197 shares of the company’s stock worth $1,917,000 after buying an additional 618 shares during the last quarter. Cullinan Associates Inc. boosted its position in shares of Procter & Gamble by 1.1% in the 3rd quarter. Cullinan Associates Inc. now owns 224,739 shares of the company’s stock worth $32,650,000 after buying an additional 2,548 shares in the last quarter. Cooper Haims Advisors LLC grew its stake in Procter & Gamble by 3.2% in the 3rd quarter. Cooper Haims Advisors LLC now owns 3,299 shares of the company’s stock valued at $479,000 after acquiring an additional 101 shares during the last quarter. J. Derek Lewis & Associates Inc. acquired a new stake in Procter & Gamble in the 3rd quarter valued at about $293,000. Finally, Henderson Brothers Financial Partners LLC increased its holdings in Procter & Gamble by 6.0% during the 3rd quarter. Henderson Brothers Financial Partners LLC now owns 2,160 shares of the company’s stock valued at $314,000 after acquiring an additional 123 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.
Insider Transactions at Procter & Gamble
In other Procter & Gamble news, CAO Matthew W. Janzaruk sold 9,479 shares of the firm’s stock in a transaction dated Tuesday, November 3rd. The stock was sold at an average price of $163.00, for a total value of $1,545,077.00. Following the sale, the chief accounting officer directly owned 1,271 shares of the company’s stock, valued at approximately $207,173. This trade represents a 88.18% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Victor Aguilar sold 18,812 shares of Procter & Gamble stock in a transaction dated Friday, October 30th. The shares were sold at an average price of $164.43, for a total value of $3,093,257.16. Following the completion of the sale, the insider owned 55,243 shares of the company’s stock, valued at $9,083,606.49. This trade represents a 25.40% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders sold 161,709 shares of company stock valued at $26,244,058. Corporate insiders own 0.23% of the company’s stock.
More Procter & Gamble News
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: P&G has raised its dividend for 70 consecutive years. Its quarterly payout is about $1.09 per share, equivalent to a roughly 2.6% yield, supporting the stock’s appeal to income-focused investors. Article: P&G dividend history and yield
- Positive Sentiment: Recent coverage points to investor interest in consumer-staples stocks as technology shares weaken. P&G may benefit from its defensive profile and dividend reputation. Article: Consumer staples rotation
- Neutral Sentiment: Zacks Research made mixed earnings-estimate changes: it lowered several forecasts for 2027 and 2028, while modestly raising some later-period estimates. The mixed revisions offer no clear overall change in the longer-term outlook. Procter & Gamble analyst estimates
- Neutral Sentiment: Management will discuss strategy and P&G’s long-term transformation at an Investor Day webcast on November 19; investors may look for updates on growth and execution. Article: P&G Investor Day webcast
- Negative Sentiment: CFO Andre Schulten sold 33,624 shares for about $5.55 million, reducing his direct stake by roughly 34%. The sale may concern investors, although insider transactions alone do not establish a change in the company’s prospects. Article: CFO share sale
Analyst Ratings Changes
A number of brokerages have issued reports on PG. Argus cut shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Friday, August 7th. The Goldman Sachs Group reiterated a “neutral” rating and issued a $161.00 price target on shares of Procter & Gamble in a research report on Thursday, October 22nd. Weiss Ratings reiterated a “hold (c)” rating on shares of Procter & Gamble in a research report on Monday, September 21st. DZ Bank cut shares of Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 27th. Finally, Piper Sandler lifted their price objective on Procter & Gamble from $145.00 to $167.00 and gave the stock a “neutral” rating in a research report on Monday, October 26th. Fifteen research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. Based on data from MarketBeat.com, Procter & Gamble presently has a consensus rating of “Moderate Buy” and a consensus price target of $170.57.
Read Our Latest Stock Analysis on Procter & Gamble
Procter & Gamble Stock Down 1.1%
Shares of NYSE PG opened at $165.31 on Friday. The firm has a market cap of $383.15 billion, a P/E ratio of 24.90, a price-to-earnings-growth ratio of 4.07 and a beta of 0.36. The company has a debt-to-equity ratio of 0.40, a quick ratio of 0.53 and a current ratio of 0.72. Procter & Gamble Company has a 1 year low of $137.62 and a 1 year high of $170.52. The firm’s 50 day moving average price is $152.01 and its 200 day moving average price is $149.43.
Procter & Gamble (NYSE:PG – Get Free Report) last issued its quarterly earnings results on Thursday, October 22nd. The company reported $2.00 earnings per share for the quarter, beating the consensus estimate of $1.89 by $0.11. Procter & Gamble had a return on equity of 31.02% and a net margin of 18.23%. The company had revenue of $23.28 billion during the quarter, compared to the consensus estimate of $22.80 billion. During the same period in the previous year, the firm posted $1.99 EPS. Procter & Gamble’s revenue was up 4.0% on a year-over-year basis. As a group, sell-side analysts anticipate that Procter & Gamble Company will post 6.99 earnings per share for the current year.
Procter & Gamble Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Monday, November 16th. Investors of record on Friday, October 23rd will be paid a $1.0885 dividend. This represents a $4.35 annualized dividend and a yield of 2.6%. The ex-dividend date is Friday, October 23rd. Procter & Gamble’s dividend payout ratio is presently 65.51%.
Procter & Gamble Company Profile
See Also
- Five stocks we like better than Procter & Gamble
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
